Seattle-area biotech experts are eying the past warily in the wake of this week’s news that Pfizer plans to acquire Bothell, Wash.-based Seagen for a whopping $43 billion. Most previous… Read More
A biotech startup spun out of the University of Washington and led by veterans of Seattle-area biotech giant Seagen has raised $4.4 million, part of an ongoing seed round. The… Read More